Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-10-2019 | Glaucoma

Acute and chronic optic nerve head biomechanics and intraocular pressure changes in patients receiving multiple intravitreal injections of anti-VEGF

Authors: M. Gómez-Mariscal, B. Puerto, F. J. Muñoz-Negrete, V. de Juan, G. Rebolleda

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 10/2019

Abstract

Purpose

To evaluate acute and chronic changes in optic nerve head (ONH) structures and intraocular pressure (IOP) in patients receiving intravitreal injections (IVIs) of anti-VEGF.

Methods

Twenty-nine eyes receiving IVIs for the first time were studied. IOP, retinal nerve fiber layer (RNFL) thickness, and ONH structures were evaluated by Spectralis optical coherence tomography with enhanced depth imaging technology. Structures were measured before and 5 min after each one of the three monthly injections of a loading dose treatment. In 13 eyes (44.8%) with more than six IVIs, another evaluation pre and immediately postinjection was performed after 1 year.

Results

A significant acute and transient IOP increase (all p ≤ 0.001), Bruch’s membrane opening (BMO) enlargement (p ≤ 0.001), cup widening (p < 0.05) and deepening (p ≤ 0.001), and prelaminar tissue thinning (p ≤ 0.001) were observed 5 min after each injection. Compared with baseline values, a significant BMO expansion (p = 0.001) and RNFL thinning (p < 0.001) were observed in the third month. In eyes with more than six IVIs, similar immediate postinjection changes, including IOP increase (p = 0.001), prelaminar tissue thinning (p = 0.007), and cup deepening (p = 0.012) were observed at 1 year, while BMO expansion was not significant (p = 0.556). Compared with baseline preinjection values, a significant BMO expansion (p = 0.003), prelaminar tissue thinning (p = 0.011), and cup deepening (p = 0.006) in the inferior region of the ONH occurred. No change in IOP was observed at the end of follow-up.

Conclusions

Repeated IVIs could lead to irreversible changes in ONH structures. Large-scale, prospective studies are required to determine the long-term effects of anti-VEGF treatments in ONH tissues.

Schlingemann R, Witmer A (2009) Treatment of retinal diseases with VEGF antagonists. Prog Brain Res 175:253–267. https://doi.org/10.1016/S0079-6123(09)17517-9 CrossRefPubMed

Falkenstein I, Cheng L, Freeman W (2007) Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin). Retina 27:1044–1047CrossRefPubMed

Kim J, Mantravadi A, Hur E, Covert D (2008) Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 146:930–934. https://doi.org/10.1016/j.ajo.2008.07.007 CrossRefPubMed

Bakri S, Pulido J, McCannel C et al (2009) Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye 23:181–185CrossRefPubMed

Kotliar K, Maier M, Bauer S, Al E (2007) Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model. Acta Ophthalmol Scand 85:777–781CrossRefPubMed

Rebolleda G, Puerto B, de Juan V et al (2016) Optic nerve head biomechanic and IOP changes before and after the injection of aflibercept for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 57:5688–5695. https://doi.org/10.1167/iovs.16-20111 CrossRefPubMed

Bakri S, McCannel C, Edwards A, Moshfeghi D (2008) Persistent ocular hypertension following intravitreal ranibizumab. Graefes Arch Clin Exp Ophthalmol 246:955–958. https://doi.org/10.1007/s00417-008-0819-2 CrossRefPubMed

Adelman R, Zheng Q, Mayer H (2010) Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections. J Ocul Pharmacol Ther 26:105–110. https://doi.org/10.1089/jop.2009.0076 CrossRefPubMed

Good T, Kimura A, Mandava N, Kahook M (2011) Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol 95:1111–1114. https://doi.org/10.1136/bjo.2010.180729 CrossRefPubMed

10.

Mathalone N, Arodi-Golan A, Sar S, Al E (2012) Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 250:1435–1440. https://doi.org/10.1007/s00417-012-1981-0 CrossRefPubMed

11.

Tseng J, Vance S, Della Torre K, Al E (2012) Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. J Glaucoma 21:241–247. https://doi.org/10.1097/IJG.0b013e31820d7d19 CrossRefPubMed

12.

Bakri S, Moshfeghi D, Francom S et al (2014) Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials. Ophthalmology 121:1102. https://doi.org/10.1016/j.ophtha.2013.11.029 CrossRefPubMed

13.

Eadie B, Etminan M, Carleton B et al (2017) Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery. JAMA Ophthalmol 135:363–368. https://doi.org/10.1001/jamaophthalmol.2017.0059 CrossRefPubMedPubMedCentral

14.

Atchison E, Wood K, Mattox C et al (2018) The real-world effect of intravitreous anti-vascular endothelial growth factor drugs on intraocular pressure: an analysis using the IRIS registry. Ophthalmology 125:676–682. https://doi.org/10.1016/j.ophtha.2017.11.027 CrossRefPubMed

15.

Lee E, Kim T, Weinreb R et al (2011) Visualization of the lamina cribrosa using enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 152:87–95. https://doi.org/10.1016/j.ajo.2011.01.024 CrossRefPubMed

16.

Liu J, He X (2009) Corneal stiffness affects IOP elevation during rapid volume change in the eye. Invest Ophthalmol Vis Sci 50:2224–2229. https://doi.org/10.1167/iovs.08-2365 CrossRefPubMed

17.

Morris H, Tang J, Cruz Perez B et al (2013) Correlation between biomechanical responses of posterior sclera and IOP elevations during micro intraocular volume change. Invest Ophthalmol Vis Sci 54:7215–7222. https://doi.org/10.1167/iovs.13-12441 CrossRefPubMedPubMedCentral

18.

Sigal I, Grimm J, Jan N et al (2014) Eye-specific IOP-induced displacements and deformations of human lamina cribrosa. Invest Ophthalmol Vis Sci 55:1–15. https://doi.org/10.1167/iovs.13-12724 CrossRefPubMedPubMedCentral

19.

Downs J, Roberts M, Burgoyne C (2008) Mechanical environment of the optic nerve head in glaucoma. Optom Vis Sci 85:425–435. https://doi.org/10.1097/OPX.0b013e31817841cb CrossRefPubMedPubMedCentral

20.

Shelton L, Rada J (2007) Effects of cyclic mechanical stretch on extracellular matrix synthesis by human scleral fibroblasts. Exp Eye Res 84:314–322CrossRefPubMed

21.

Wang G, Chen W (2012) Effects of mechanical stimulation on viscoelasticity of rabbit scleral fibroblasts after posterior scleral reinforcement. Exp Biol Med 237:1150–1154. https://doi.org/10.1258/ebm.2012.012196 CrossRef

22.

Goktas A, Goktas S, Atas M et al (2013) Short-term impact of intravitreal ranibizumab injection on axial ocular dimension and intraocular pressure. Cutan Ocul Toxicol 32:23–26. https://doi.org/10.3109/15569527.2012.696569 CrossRefPubMed

23.

Gismondi M, Salati C, Salvetat M et al (2009) Short term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure. J Glaucoma 18:658–661. https://doi.org/10.1097/IJG.0b013e31819c4893 CrossRefPubMed

24.

Menzel C, Kotliar K, Lanzl I (2009) Retrospective investigation of seasonal factors influencing intraocular pressure in glaucoma patients. Ophthalmologe 106:1006–1011. https://doi.org/10.1007/s00347-008-1882-0 CrossRefPubMed

25.

Qureshi I, Xiao R, Yang B et al (1999) Seasonal and diurnal variations of ocular pressure in ocular hypertensive subjects in Pakistan. Singap Med J 40:345–348

26.

Cacciamani A, Oddone F, Parravano M et al (2013) Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length. Jpn J Ophthalmol 57:63–67. https://doi.org/10.1007/s10384-012-0194-8 CrossRefPubMed

27.

Radius R (1981) Regional specificity in anatomy at the lamina cribrosa. Arch Ophthalmol 99:478–480CrossRefPubMed

28.

Quigley H, Addicks E (1981) Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol 99:137–143CrossRefPubMed

29.

Winkler M, Jester B, Nien-Shy C et al (2010) High resolution three-dimensional reconstruction of the collagenous matrix of the human optic nerve head. Brain Res Bull 81:339–348CrossRefPubMed

30.

Roberts M, Liang Y, Sigal I, Al E (2010) Correlation between local stress and strain and lamina cribrosa connective tissue volume fraction in normal monkey eyes. Invest Ophthalmol Vis Sci 51:295–307. https://doi.org/10.1167/iovs.09-4016 CrossRefPubMedPubMedCentral

31.

Bracha P, Moore N, Ciulla T et al (2018) The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review. Surv Ophthalmol 63:281–295. https://doi.org/10.1016/j.survophthal.2017.08.008 CrossRefPubMed

32.

Hoguet A, Chen P, Junk A et al (2019) The effect of anti-vascular endothelial growth factor agents on intraocular pressure and glaucoma: a report by the american academy of ophthalmology. Ophthalmology 126:611–622. https://doi.org/10.1016/j.ophtha.2018.11.019 CrossRefPubMed

33.

Shin H, Kim S, Chung H et al (2016) Intravitreal anti-vascular endothelial growth factor therapy and retinal nerve fiber layer loss in eyes with age-related macular degeneration: a meta-analysis. Invest Ophthalmol Vis Sci 57:1798–1806. https://doi.org/10.1167/iovs.15-18404 CrossRefPubMed

34.

Soheilian M, Karimi S, Montahae T et al (2017) Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study. Graefes Arch Clin Exp Ophthalmol 255:1705–1712. https://doi.org/10.1007/s00417-017-3702-1 CrossRefPubMed

35.

Martinez-de-la-Casa J, Ruiz-Calvo A, Saenz-Frances F et al (2012) Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab. Invest Ophthalmol Vis Sci 53:6214–6218. https://doi.org/10.1167/iovs.12-9875 CrossRefPubMed

36.

Horsley M, Mandava N, Maycotte M, Kahook M (2010) Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy. Am J Ophthalmol 150:558–561. https://doi.org/10.1016/j.ajo.2010.04.029 CrossRefPubMed

37.

Shin H, Shin K, Chung H, Kim H (2014) Change of retinal nerve fiber layer thickness in various retinal diseases treated with multiple intravitreal antivascular endothelial growth factor. Invest Ophthalmol Vis Sci 55:2403–2411. https://doi.org/10.1167/iovs.13-13769 CrossRefPubMed

38.

Zucchiatti I, Cicinelli M, Parodi M et al (2017) Effect of intravitreal ranibizumab on ganglion cell complex and peripapillary retinal nerve fiber layer in neovascular age-related macular degeneration using spectral domain optical coherence tomography. Retina 37:1314–1319. https://doi.org/10.1097/IAE.0000000000001360 CrossRefPubMed

Title: Acute and chronic optic nerve head biomechanics and intraocular pressure changes in patients receiving multiple intravitreal injections of anti-VEGF
Authors: M. Gómez-Mariscal
B. Puerto
F. J. Muñoz-Negrete
V. de Juan
G. Rebolleda
Publication date: 01-10-2019
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 10/2019
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-019-04354-7

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Acute and chronic optic nerve head biomechanics and intraocular pressure changes in patients receiving multiple intravitreal injections of anti-VEGF

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2019

Cytokine production in thyroid eye disease: in vitro effects of dexamethasone and IL-6 blockade with tocilizumab

Reduced baseline diameter and contraction of peripheral retinal arterioles immediately after remote ischemia in diabetic patients

Exploration of potential key pathways and genes in multiple ocular cancers through bioinformatics analysis

Evaluation of lamina cribrosa thickness in patients diagnosed with central retinal vein occlusion

Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage

Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis